Edesa Biotech
EDSA
9 hedge funds and large institutions have $151K invested in Edesa Biotech in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
0.03% less ownership
Funds ownership: 0.08% → 0.05% (-0.03%)
46% less capital invested
Capital invested by funds: $280K → $151K (-$129K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.03K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.52K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$544 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$36 |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$36 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$59.5K |
| 2 |
Renaissance Technologies
New York
|
-$29.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $98K | -$29.5K | -812 | -27% |
|
|
2
Morgan Stanley
New York
| $37K | -$59.5K | -1,638 | -66% |
|
|
3
UBS Group
Zurich,
Switzerland
| $8K | +$1.52K | +42 | +30% |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $7K | +$6.03K | +166 | New |
|
|
AG
5
Advisor Group
Phoenix,
Arizona
| $1K | +$544 | +15 | +167% |
|
|
6
Bank of America
Charlotte,
North Carolina
| – | +$36 | +1 | New |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$36 | +1 | +100% |
|
EDSA Hedge Fund Activity: Q3 2019 in Review
9 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2019, worth a combined $151K — down 46% from $280K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new EDSA positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Deutsche Bank, opening a new position worth an estimated $6.03K. The largest seller was Morgan Stanley, cutting an estimated $59.5K.
- 9 institutional investors held Edesa Biotech (EDSA) as of Q3 2019, up from 8 in Q2 2019.
- Funds reported $151K of Edesa Biotech stock for Q3 2019, down 46% quarter-over-quarter.
- 2 funds opened new Edesa Biotech positions in Q3 2019 and 1 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q3 2019 was Deutsche Bank, an estimated $6.03K added.
- The largest Edesa Biotech seller in Q3 2019 was Morgan Stanley, an estimated $59.5K sold.
Based on aggregated 13F filings for Q3 2019.